BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32545483)

  • 21. Pan-cancer analysis identifies mutations in
    Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
    Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M
    Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
    Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
    Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
    Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
    Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
    J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer.
    Shi H; Zhang Y; Liu J; Wang Y; Fang P
    Adv Clin Exp Med; 2024 Jan; 33(1):79-90. PubMed ID: 37341175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
    Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
    Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
    Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
    Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Understanding and therapeutic targeting of aberrant mRNA splicing mechanisms in oncogenesis].
    Tanaka A; Kobayashi S; Xiao M; Inoue D
    Rinsho Ketsueki; 2020; 61(6):643-650. PubMed ID: 32624538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative splicing of S6K1 promotes non-small cell lung cancer survival.
    Mei H; Wang Y; Fan J; Lin Z
    Tumour Biol; 2016 Oct; 37(10):13369-13376. PubMed ID: 27460085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
    Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
    BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
    Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
    Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
    Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).
    Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
    Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibition of the spliceosome subunit SF3b triggers exon junction complex-independent nonsense-mediated decay.
    Carvalho T; Martins S; Rino J; Marinho S; Carmo-Fonseca M
    J Cell Sci; 2017 May; 130(9):1519-1531. PubMed ID: 28302904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
    de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
    Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.
    Kim Guisbert KS; Guisbert E
    PLoS One; 2017; 12(4):e0176382. PubMed ID: 28445500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
    Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
    Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.